Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.232
-0.014 (-1.12%)
Apr 14, 2026, 4:41 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 193.73 million as of April 14, 2026. Its market cap has decreased by -77.63% in one year.
Market Cap
193.73M
Enterprise Value
3.00M
Revenue
362.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.23
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 193.73M, an increase of 46.20%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 193.11M | -87.53% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 273.26M |
| Xintela AB | 248.91M |
| Initiator Pharma | 224.53M |
| Alligator Bioscience AB | 217.32M |
| Isofol Medical AB | 189.19M |
| Active Biotech AB | 175.83M |
| AlzeCure Pharma AB | 164.90M |
| Xbrane Biopharma AB | 161.96M |